We are live on ! Find out more
ONCY

Oncolytics Biotech
ONCY

21 hedge funds and large institutions have $225K invested in Oncolytics Biotech in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

5% more funds holding

Funds holding: 20 → 21 (+1)

1.25% less ownership

Funds ownership: 2.84% → 1.58% (-1.3%)

77% less capital invested

Capital invested by funds: $981K → $225K (-$756K)

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$149K
2
Renaissance Technologies
Renaissance Technologies
New York
+$38.4K
3
Citadel Advisors
Citadel Advisors
Florida
+$17.2K
4
MFG
Magnus Financial Group
New York
+$15.3K
5
Deutsche Bank
Deutsche Bank
Germany
+$8.84K

Top Sellers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
-$695K
2
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
-$1K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$523
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$115K +$149K +146,549 +260%
SC
2
Scotia Capital
Ontario, Canada
$28K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$22K +$38.4K +37,751 New
MFG
4
Magnus Financial Group
New York
$14K +$15.3K +15,000 +150%
Citadel Advisors
5
Citadel Advisors
Florida
$10K +$17.2K +16,916 New
Comerica Bank
6
Comerica Bank
Texas
$8K – – –
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$7K +$256 +251 +2%
Deutsche Bank
8
Deutsche Bank
Germany
$7K +$8.84K +8,679 +189%
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4.58K – – –
Bank of Montreal
10
Bank of Montreal
Ontario, Canada
$4K -$523 -514 -8%
Toronto Dominion Bank
11
Toronto Dominion Bank
Ontario, Canada
$3K +$4.58K +4,500 New
LTFS
12
Ladenburg Thalmann Financial Services
Florida
$1K – – –
NFG
13
Next Financial Group
Texas
$1K – – –
Verition Fund Management
14
Verition Fund Management
Connecticut
– -$695K -408,838 Closed
CAPTRUST Financial Advisors
15
CAPTRUST Financial Advisors
North Carolina
– -$1K -440 Closed

ONCY Hedge Fund Activity: Q3 2019 in Review

21 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q3 2019, worth a combined $225K — down 77% from $981K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ONCY positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $149K. The largest seller was Verition Fund Management, exiting entirely with an estimated $695K sold.

  • 21 institutional investors held Oncolytics Biotech (ONCY) as of Q3 2019, up from 20 in Q2 2019.
  • Funds reported $225K of Oncolytics Biotech stock for Q3 2019, down 77% quarter-over-quarter.
  • 3 funds opened new Oncolytics Biotech positions in Q3 2019 and 2 closed out, a net change of +1 holder.
  • The largest Oncolytics Biotech buyer in Q3 2019 was Morgan Stanley, an estimated $149K added.
  • The largest Oncolytics Biotech seller in Q3 2019 was Verition Fund Management, an estimated $695K sold.

Based on aggregated 13F filings for Q3 2019.